Host-Cell Proteins: Implications for Protein-Drug Efficacy - BioProcess InternationalBioProcess International

Host cell protein content is often identified as a critical quality attribute and is often used as a benchmark during biologics manufacturing.

Methods for addressing host cell protein impurities in biopharmaceutical product development - Tuameh - 2023 - Biotechnology Journal - Wiley Online Library

PDF) Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development

HCP Enrichment During CGMP Scale-Up - BioProcess InternationalBioProcess International

Downstream Processing Archives - Page 4 of 46 - BioProcess InternationalBioProcess International

Host cell receptor/molecules/factors as therapeutic targets for

HCP Enrichment During CGMP Scale-Up - BioProcess InternationalBioProcess International

Page 640 – BioProcess InternationalBioProcess International, Covering the whole development process for the global biotechnology industry

Full article: Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development

Host-Cell Protein Measurement and Control - Bioprocess Development Forum

Sensitive, Rapid, Robust, and Reproducible Workflow for Host Cell Protein Profiling in Biopharmaceutical Process Development

Quality By Design for Monoclonal Antibodies, Part 2: Process Design Space and Control Strategies - BioProcess InternationalBioProcess International

What are Host Cell Proteins and Its Effect on Biopharmaceutical Development - Creative Proteomics